Back to Dashboard
PSNL · Healthcare

PERSONALIS INC

USA Healthcare Filing: 2025-12-31
Smart-money confidence · 1 of 3 sources firing
Bearish — money moving out

No standout activity across the feeds we track.

Hedge funds
16
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
◆ Next steps Interested in PERSONALIS INC? Here's what to do with it.
Not financial advice. Bogen Capital surfaces public SEC filings — you decide what to do with them.
Market cap
$1.3B
Industry
Diagnostics & Research
Sector
Healthcare
Exchange
NasdaqGM
About PERSONALIS INC

Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in solid tumor cancers; and ImmunoID NeXT, a tissue-based service that combines whole exome and whole transcriptome sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a…

Who's behind the signal
Every informed buyer we can see on PSNL, across all three feeds.
Hedge funds · 3
Citadel Advisors New position
AQR Capital Management New position
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trade history · 3
Every disclosed buy & sell on record — STOCK Act filings
Trade date Member Chamber Action Amount
2020-05-19 Brian J. Mast · R-FL House SOLD $15,001 - $50,000
2020-04-22 Brian J. Mast · R-FL House SOLD $1,001 - $15,000
2020-02-14 Brian J. Mast · R-FL House BOUGHT $15,001 - $50,000
Not a model pick — but on our radar. PERSONALIS INC isn't in the top-10 model right now, but 3 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
3
Investors
2
New positions
0
Increasing
0
Decreasing
1
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.0×
New position
% of portfolio
0.0%
Position change
NEW
0.0% of Citadel Advisors's portfolio
Trust weight: 1.0×
New position
% of portfolio
0.0%
Position change
NEW
0.0% of AQR Capital Management's portfolio
Trust weight: 1.3×
Unchanged
% of portfolio
0.4%
Position change
0.4% of ARK Invest's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to PERSONALIS INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell PERSONALIS INC or any security.

Get the Weekly Update

Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime